174 related articles for article (PubMed ID: 17931792)
21. c-kit and SCF expression in normal and tumor breast tissue.
Ulivi P; Zoli W; Medri L; Amadori D; Saragoni L; Barbanti F; Calistri D; Silvestrini R
Breast Cancer Res Treat; 2004 Jan; 83(1):33-42. PubMed ID: 14997053
[TBL] [Abstract][Full Text] [Related]
22. A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast.
Pathmanathan N; Salisbury EL; Provan PJ; Bilous AM; Byth K; Milliken JS; Clarke CL; Balleine RL
Pathology; 2010 Jan; 42(1):28-36. PubMed ID: 20025477
[TBL] [Abstract][Full Text] [Related]
23. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
24. Prostate-specific antigen in breast disease.
Poh BH; Jayaram G; Sthaneshwar P; Yip CH
Malays J Pathol; 2008 Jun; 30(1):43-51. PubMed ID: 19108411
[TBL] [Abstract][Full Text] [Related]
25. Cytological analysis and immunocytochemical expression of Ki67 and Bcl-2 in breast proliferative lesions.
Midulla C; Pisani T; De Iorio P; Cenci M; Divizia E; Nofroni I; Vecchione A
Anticancer Res; 2002; 22(2B):1341-5. PubMed ID: 12168948
[TBL] [Abstract][Full Text] [Related]
26. Characterization of columnar cell lesions of the breast: immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretions.
Dessauvagie BF; Zhao W; Heel-Miller KA; Harvey J; Bentel JM
Hum Pathol; 2007 Feb; 38(2):284-92. PubMed ID: 17084437
[TBL] [Abstract][Full Text] [Related]
27. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.
Andreadis D; Epivatianos A; Poulopoulos A; Nomikos A; Papazoglou G; Antoniades D; Barbatis C
Oral Oncol; 2006 Jan; 42(1):57-65. PubMed ID: 16140564
[TBL] [Abstract][Full Text] [Related]
28. The challenge of apocrine proliferations of the breast: a morphologic approach.
Masood S; Rosa M
Pathol Res Pract; 2009; 205(3):155-64. PubMed ID: 19147303
[TBL] [Abstract][Full Text] [Related]
29. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
30. Subcellular localization of HMFG2 in breast carcinomas: an immunohistochemical and immunoelectron microscopic study.
Hanna WM; Kahn HJ; Zive SE; Shackleton M; Andrighetti L
Mod Pathol; 1992 Nov; 5(6):603-6. PubMed ID: 1369793
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of the ras oncogene expression in human breast lesions.
Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
[TBL] [Abstract][Full Text] [Related]
32. Transferrin receptor expression in non-malignant and malignant human breast tissue.
Walker RA; Day SJ
J Pathol; 1986 Mar; 148(3):217-24. PubMed ID: 3009766
[TBL] [Abstract][Full Text] [Related]
33. Columnar cell lesions of the breast.
Feeley L; Quinn CM
Histopathology; 2008 Jan; 52(1):11-9. PubMed ID: 18171413
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues.
Chui X; Egami H; Yamashita J; Kurizaki T; Ohmachi H; Yamamoto S; Ogawa M
Br J Cancer; 1996 May; 73(10):1233-6. PubMed ID: 8630284
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical and morphologic findings in columnar cell lesions of the breast.
Demiralay E; Demirhan B; Kocbiyik A; Sar A; Altaca GL
Indian J Pathol Microbiol; 2011; 54(2):335-8. PubMed ID: 21623085
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors.
Ohike N; Sato M; Hisayuki T; Imataka H; Sato S; Wada Y; Saito K; Takahashi M; Tajiri T; Kunimura T; Morohoshi T
Pathol Int; 2007 Sep; 57(9):589-93. PubMed ID: 17685930
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease.
Candlish W; Kerr IB; Simpson HW
J Pathol; 1986 Nov; 150(3):163-7. PubMed ID: 3027290
[TBL] [Abstract][Full Text] [Related]
38. p21 ras protein expression in benign and malignant human breast.
Walker RA; Wilkinson N
J Pathol; 1988 Oct; 156(2):147-53. PubMed ID: 3058913
[TBL] [Abstract][Full Text] [Related]
39. c-kit expression in adenoid cystic carcinoma of the breast.
Hill PA
Pathology; 2004 Aug; 36(4):362-4. PubMed ID: 15370139
[No Abstract] [Full Text] [Related]
40. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
Tramm T; Kim JY; Leibl S; Moinfar F; Tavassoli FA
Virchows Arch; 2016 Sep; 469(3):285-95. PubMed ID: 27287269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
